Precision Optics Corp Inc (POCI)

5.60 0.00 (0.00%) USD  |  NASDAQ  |  Apr 30, 10:16
More

Precision Optics Research and Development Expense (Quarterly): 0.2217M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.
Date Value
December 31, 2023 0.2217M
September 30, 2023 0.2128M
June 30, 2023 0.3319M
March 31, 2023 0.2064M
December 31, 2022 0.1553M
September 30, 2022 0.2455M
June 30, 2022 0.2332M
March 31, 2022 0.2149M
December 31, 2021 0.1132M
September 30, 2021 0.1052M
June 30, 2021 0.1806M
March 31, 2021 0.1461M
December 31, 2020 0.146M
September 30, 2020 0.1516M
June 30, 2020 0.1855M
March 31, 2020 0.3199M
December 31, 2019 0.2286M
September 30, 2019 0.1522M
June 30, 2019 0.1574M
March 31, 2019 0.1216M
December 31, 2018 0.1254M
September 30, 2018 0.1008M
June 30, 2018 0.1216M
March 31, 2018 0.1264M
December 31, 2017 0.09M
Date Value
September 30, 2017 0.1184M
June 30, 2017 0.1056M
March 31, 2017 0.1223M
December 31, 2016 0.1192M
September 30, 2016 0.117M
June 30, 2016 0.1011M
March 31, 2016 0.1183M
December 31, 2015 0.1081M
September 30, 2015 0.1508M
June 30, 2015 0.1372M
March 31, 2015 0.1402M
December 31, 2014 0.1389M
September 30, 2014 0.0767M
June 30, 2014 0.1111M
March 31, 2014 0.133M
December 31, 2013 0.0921M
September 30, 2013 0.1349M
June 30, 2013 0.0969M
March 31, 2013 0.1595M
December 31, 2012 0.1667M
September 30, 2012 0.2073M
June 30, 2012 0.1659M
March 31, 2012 0.1986M
December 31, 2011 0.149M
September 30, 2011 0.1512M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.1052M
Minimum
Sep 2021
0.3319M
Maximum
Jun 2023
0.1951M
Average
0.1855M
Median
Jun 2020

Research and Development Expense (Quarterly) Benchmarks

AptarGroup Inc --
Daxor Corp --
Sanara MedTech Inc 0.6515M
Warby Parker Inc --
Perspective Therapeutics Inc 6.08M